ScoreWhy is Guangdong Jiaying Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 6.47%
- The company has been able to generate a Return on Capital Employed (avg) of 6.47% signifying low profitability per unit of total capital (equity and debt)
2
The company has declared negative results for the last 2 consecutive quarters
- INTEREST(HY) At CNY 0.27 MM has Grown at 6,830.93%
- OPERATING CASH FLOW(Y) Lowest at CNY -13.33 MM
- NET PROFIT(HY) At CNY 22.06 MM has Grown at -34.46%
3
With ROE of 3.83%, it has a very expensive valuation with a 2.43 Price to Book Value
- Over the past year, while the stock has generated a return of -45.07%, its profits have fallen by -10.3%
4
Below par performance in long term as well as near term
- Along with generating -45.07% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Guangdong Jiaying Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Guangdong Jiaying Pharmaceutical Co., Ltd.
-42.05%
-1.11
44.32%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-7.51%
EBIT Growth (5y)
-0.29%
EBIT to Interest (avg)
30.53
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
0.57
Tax Ratio
12.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.33%
ROE (avg)
3.75%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
54
Industry P/E
Price to Book Value
2.08
EV to EBIT
41.01
EV to EBITDA
27.07
EV to Capital Employed
2.32
EV to Sales
3.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.67%
ROE (Latest)
3.83%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -34.55% (YoY
-43What is not working for the Company
INTEREST(9M)
At CNY 0.42 MM has Grown at 10,409.67%
OPERATING CASH FLOW(Y)
Lowest at CNY -19.97 MM
ROCE(HY)
Lowest at -0.36%
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.81 times
CASH AND EQV(HY)
Lowest at CNY 280.79 MM
DEBT-EQUITY RATIO
(HY)
Highest at -13.05 %
NET SALES(Q)
Lowest at CNY 42.83 MM
OPERATING PROFIT(Q)
Lowest at CNY -15.76 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -36.8 %
PRE-TAX PROFIT(Q)
Lowest at CNY -22.91 MM
NET PROFIT(Q)
Lowest at CNY -24.55 MM
EPS(Q)
Lowest at CNY -0.05
Here's what is working for Guangdong Jiaying Pharmaceutical Co., Ltd.
Raw Material Cost
Fallen by -34.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Guangdong Jiaying Pharmaceutical Co., Ltd.
Interest
At CNY 0.42 MM has Grown at 10,409.67%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 42.83 MM has Fallen at -43.55%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -22.91 MM has Fallen at -542.41%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -24.55 MM has Fallen at -640.6%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY -19.97 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debtors Turnover Ratio
Lowest at 1.81 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Net Sales
Lowest at CNY 42.83 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY -15.76 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -36.8 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY -22.91 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY -24.55 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY -0.05
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Cash and Eqv
Lowest at CNY 280.79 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -13.05 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
